Clement Douault
7Patents
1h-index
15Co-inventors
40Inventor score
Filing activity: Apr 27, 2011 → Jul 18, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8633319B2 | 7-(1H-pyrazol-4-yl)-1,6-naphthyridine compounds as Syk inhibitors | Human Necessities | 6 | Active |
| US10039755B2 | 2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors | Human Necessities | 1 | Active |
| US9518054B2 | 2-(azaindol-2-yl) benz imidazoles as PAD4 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9833449B2 | 2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9127003B2 | 2-(azaindol-2-yl)benzimidazoles as PAD4 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10815218B2 | Benzoimidazole derivatives as PAD4 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10407407B2 | Benzoimidazole derivatives as PAD4 inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.